Red Flags Detected

  • Going Concern (worsened) — Cash runway shortened from August 2025 to June 2026 despite one year passing and equity raises, indicating accelerated burn rate outpacing revenue growth.
NASDAQ: BIAFW bioAffinity Technologies, Inc. 10-Q

bioAffinity narrows cash runway to one month as losses widen despite 146% test sales surge

Filed May 11, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade BIAFW commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov View full financials on EDGAR ↗

Generated by AI · Jun 1, 2026 8:20 PM